/

Workspace

Research & Review

Writing & Publishing

Data & Analysis

Utilities

Account

User Settings

T

Takanori Ishida

Toho University(JP)

Claim or correct this author profile

Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.

316

Papers

7.6K

Citations

50

h-index

149

i10-index

Takanori Ishida is an academic researcher from Toho University. The author has contributed to research in topics: Breast Cancer Treatment Studies & Estrogen and related hormone effects & Breast Lesions and Carcinomas. The author has an h-index of 50, co-authored 269 publications.

ORCID: 0000-0003-4565-4721

Research Topics

Breast Cancer Treatment Studies Estrogen and related hormone effects Breast Lesions and Carcinomas HER2/EGFR in Cancer Research Global Cancer Incidence and Screening

Papers by this author

works

Prognostic significance of tumor-infiltrating CD8+ and FOXP3+ lymphocytes in residual tumors and alterations in these parameters after neoadjuvant chemotherapy in triple-negative breast cancer: a retrospective multicenter study

2015 · Breast Cancer Research · 247 citations

https://doi.org/10.1186/s13058-015-0632-x

Minoru Miyashita Hironobu Sasano Kentaro Tamaki Hisashi Hirakawa

Comparison of core needle biopsy (CNB) and surgical specimens for accurate preoperative evaluation of ER, PgR and HER2 status of breast cancer patients

2010 · Cancer Science · 100 citations

https://doi.org/10.1111/j.1349-7006.2010.01630.x

Kentaro Tamaki Hironobu Sasano Takanori Ishida Minoru Miyashita

Runx2 in human breast carcinoma: its potential roles in cancer progression

2010 · Cancer Science · 78 citations

https://doi.org/10.1111/j.1349-7006.2010.01742.x

Yoshiaki Onodera Yasuhiro Miki Takashi Suzuki Kiyoshi Takagi

In vivo single molecular imaging and sentinel node navigation by nanotechnology for molecular targeting drug-delivery systems and tailor-made medicine

2008 · Breast Cancer · 59 citations

https://doi.org/10.1007/s12282-008-0037-0

Motohiro Takeda Hiroshi Tada Hideo Higuchi Yoshio Kobayashi

Adjuvant S-1 plus endocrine therapy for oestrogen receptor-positive, HER2-negative, primary breast cancer: a multicentre, open-label, randomised, controlled, phase 3 trial

2020 · The Lancet Oncology · 57 citations

https://doi.org/10.1016/s1470-2045(20)30534-9

Masakazu Toi Shigeru Imoto Takanori Ishida Yoshinori Ito

Immunolocalization of liver receptor homologue-1 (LRH-1) in human breast carcinoma: Possible regulator of in situ steroidogenesis

2006 · Cancer Letters · 55 citations

https://doi.org/10.1016/j.canlet.2005.11.038

Yasuhiro Miki Colin D. Clyne Takashi Suzuki Takuya Moriya

Research topics

topics

Breast Cancer Treatment Studies

Estrogen and related hormone effects

Breast Lesions and Carcinomas

HER2/EGFR in Cancer Research

Global Cancer Incidence and Screening

Chat about Author

Papers

Chat

Click to start Chat